We are live on ! Find out more
BHC icon

Bausch Health
BHC

Fund managers haven’t disclosed any holdings of BHC yet.

BHC Hedge Fund Activity: Q1 2026 in Review

227 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2026, worth a combined $1.27B — down 23% from $1.64B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of BHC and 30 opened new positions — a net loss of 4 holders — while 59 trimmed existing stakes and 83 added.

The largest buyer was Nuveen, adding an estimated $20.7M. The largest seller was National Bank of Canada, cutting an estimated $29.5M.

  • 227 institutional investors held Bausch Health (BHC) as of Q1 2026, down from 235 in Q4 2025.
  • Funds reported $1.27B of Bausch Health stock for Q1 2026, down 23% quarter-over-quarter.
  • 30 funds opened new Bausch Health positions in Q1 2026 and 34 closed out, a net change of -4 holders.
  • The largest Bausch Health buyer in Q1 2026 was Nuveen, an estimated $20.7M added.
  • The largest Bausch Health seller in Q1 2026 was National Bank of Canada, an estimated $29.5M sold.

Based on aggregated 13F filings for Q1 2026.